Item 7.01 Financial Regulation FD Disclosure.
On November 15, 2022, CONMED Corporation (the "Company") issued a press release
withdrawing its full year 2022 financial outlook as a result of the temporary
disruption from a software implementation. The Company also provided its 2023
financial outlook. A copy of this press release is attached hereto as Exhibit
99.1.
On November 15, 2022, Curt R. Hartman, the Company's Chief Executive Officer,
and Todd W. Garner, the Company's Chief Financial Officer, plan to appear at the
Stifel 2022 Healthcare Conference to discuss the Company's objectives, strategy
and recent events, including the issues discussed in the press release. A copy
of the Company's updated investor presentation is attached hereto as Exhibit
99.2.
Item 8.01 Other Events.
In October 2022, the Company implemented new warehouse software, which caused
service level disruptions that impacted the Company's ability to ship certain
quantities of finished goods to customers. Although the Company believes that
the impact to sales, if any, will be limited to the fourth quarter of 2022, the
Company cannot provide assurances that the resolution of service level and
shipping disruptions will fully recover these sales in the fourth quarter of
2022 and/or that the warehouse management software implementation will not
disrupt the Company's operations and its ability to fulfill customer orders.
Also, these disruptions have caused the Company to incur other costs and
expenses in connection with the resolution of the service level and shipping
disruptions. To the extent that these disruptions recur and/or persist over
time, this could negatively impact the Company's competitive position and its
relationships with its customers and thus could have a material adverse effect
on the Company's business, prospects, results of operations, financial condition
and/or cash flows.
The information in this Current Report on Form 8-K that is furnished under "Item
7.01. Financial Regulation FD Disclosure" and Exhibit 99.1 and Exhibit 99.2
attached hereto shall not be deemed "filed" for purposes of Section 18 of the
Securities Act of 1934, nor shall they be deemed incorporated by reference in
any filing under the Securities Act of 1933, except as shall be expressly set
forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are included herewith:
Exhibit No. Description of Exhibit
99.1 Press Release dated November 15, 2022, issued by CONMED
Corporation.
99.2 Investor Presentation dated November 15, 2022, issued by CONMED
Corporation.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses